Ligne de temps

18 Feb 2019
publication

Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth

Lire plus
24 Sep 2018
publication

Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4

Lire plus
20 Mar 2017
publication

Measurement of Dipeptidylpeptidase Activity in vitro and in vivo.

Lire plus
24 Sep 2015
publication

RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells

Lire plus
15 Jun 2015
publication

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

Lire plus